143 related articles for article (PubMed ID: 21266946)
21. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
22. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
[TBL] [Abstract][Full Text] [Related]
23. Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians.
Souza RP; Remington G; Chowdhury NI; Lau MK; Voineskos AN; Lieberman JA; Meltzer HY; Kennedy JL
Eur Neuropsychopharmacol; 2010 Oct; 20(10):688-94. PubMed ID: 20605420
[TBL] [Abstract][Full Text] [Related]
24. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
[TBL] [Abstract][Full Text] [Related]
25. Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men.
Russo P; Strazzullo P; Cappuccio FP; Tregouet DA; Lauria F; Loguercio M; Barba G; Versiero M; Siani A
J Clin Endocrinol Metab; 2007 Jun; 92(6):2382-6. PubMed ID: 17405839
[TBL] [Abstract][Full Text] [Related]
26. Association study between the neurexin-1 gene and tardive dyskinesia.
Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC
Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489
[TBL] [Abstract][Full Text] [Related]
27. [Genome-wide association analyses for neuroleptic-induced tardive dyskinesia].
Arinami T; Inada T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):155-62. PubMed ID: 21941849
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
[TBL] [Abstract][Full Text] [Related]
29. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
Ho BC; Wassink TH; Ziebell S; Andreasen NC
Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
[TBL] [Abstract][Full Text] [Related]
31. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
Juhasz G; Chase D; Pegg E; Downey D; Toth ZG; Stones K; Platt H; Mekli K; Payton A; Elliott R; Anderson IM; Deakin JF
Neuropsychopharmacology; 2009 Jul; 34(8):2019-27. PubMed ID: 19242408
[TBL] [Abstract][Full Text] [Related]
32. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
33. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.
Utsunomiya K; Shinkai T; Sakata S; Yamada K; Chen HI; De Luca V; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2012 Jan; 507(1):52-6. PubMed ID: 22172931
[TBL] [Abstract][Full Text] [Related]
34. The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.
Gouvêa ES; Santos AF; Ota VK; Mrad V; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
Braz J Psychiatry; 2017; 39(2):160-171. PubMed ID: 28099629
[TBL] [Abstract][Full Text] [Related]
35. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.
Agrawal A; Wetherill L; Dick DM; Xuei X; Hinrichs A; Hesselbrock V; Kramer J; Nurnberger JI; Schuckit M; Bierut LJ; Edenberg HJ; Foroud T
Am J Med Genet B Neuropsychiatr Genet; 2009 Jul; 150B(5):736-40. PubMed ID: 19016476
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia.
Chavarría-Siles I; Contreras-Rojas J; Hare E; Walss-Bass C; Quezada P; Dassori A; Contreras S; Medina R; Ramírez M; Salazar R; Raventos H; Escamilla MA
Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):279-84. PubMed ID: 18186055
[TBL] [Abstract][Full Text] [Related]
37. Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Zai CC; Romano-Silva MA; Hwang R; Zai GC; Deluca V; Müller DJ; King N; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
Schizophr Res; 2008 Dec; 106(2-3):248-52. PubMed ID: 18838251
[TBL] [Abstract][Full Text] [Related]
38. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid Receptor 1 (CNR1) 4895 C/T Genetic Polymorphism was Associated with Obesity in Japanese Men.
Mutombo PB; Yamasaki M; Nabika T; Shiwaku K
J Atheroscler Thromb; 2012; 19(8):779-85. PubMed ID: 22976112
[TBL] [Abstract][Full Text] [Related]
40. Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
Novak G; Gallo A; Zai CC; Meltzer HY; Lieberman JA; Potkin SG; Voineskos AN; Remington G; Kennedy JL; Levesque D; Le Foll B
Psychiatr Genet; 2010 Feb; 20(1):39-43. PubMed ID: 20010315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
